Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2

NCT04227535 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 509

Last updated 2023-04-28

No results posted yet for this study

Summary

The overall goal of this study is to identify risk and prognosis factors of Interstitial Lung Disease (ILD) in patients with rheumatoid arthritis (RA).

Conditions

Sponsors & Collaborators

Principal Investigators

  • Philippe DIEUDE, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2027-10-01
Completion
2027-10-01

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04227535 on ClinicalTrials.gov